• Experimental Drug Found to Improve Symptoms of Generalized Myasthenia Gravis

    1 month ago - By UNC Healthcare

    James F. Howard Jr., MD, professor in the UNC Department of Neurology, was principal investigator of the phase 3 trial for the experimental drug efgartigimod, developed by Belgian pharmaceutical company Argenx.
    Read more ...